The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Ivanov S.V.

State Research Institute for Complex Issues of Cardiovascular Diseases Municipal Budget Healthcare Institution, Kemerovo, Russia

Betamax (sulpirid): potential for clinical application

Authors:

Ivanov S.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(12): 83‑87

Read: 16169 times

Download PDF (RU)
Contact the author
Table of contents

BETAMAX (SULPIRID): POTENTIAL FOR CLINICAL APPLICATION
BETAMAX (SULPIRID): POTENTIAL FOR CLINICAL APPLICATION

To cite this article:

Ivanov SV. Betamax (sulpirid): potential for clinical application. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(12):83‑87. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Clinical and epidemiological indi­cators of stroke during the COVID-19 pandemic and in the post-COVID period in the Moscow region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):5-11
Combined treatment of patients with acute muscular tonic syndrome with dorsopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):70-77
Stress and sleep: Neurobiological aspe­cts and modern options of inso­mnia therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):14-21
Early diagnosis and effe­ctive therapy of diabetic poly­neuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):62-68
Tube­rculous otitis media in an adolescent. Clinical case. Russian Bulletin of Otorhinolaryngology. 2024;(5):63-66
Comparative analysis of the resu­lts of treatment of gastric polyps by methods of loop electroexcision, laser and endo­scopic poly­pectomy with aspi­ration capture. Endo­scopic Surgery. 2024;(6):24-30
Black Acanthosis: Diagnosis and Treatment Issues. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):709-712
Resu­lts of the All-Russian consensus conference on complications in bariatric surgery. Endo­scopic Surgery. 2025;(1):15-24
Pharmacological treatment and prevention of ischemia-reperfusion syndrome in percutaneous coro­nary inte­rvention. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):191-200
Influence of griseofulvin on inte­stinal microbiota in the treatment of microsporia in rural children. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):185-190
Abstract:

Keywords:

sulpirid
treatment

Authors:

Ivanov S.V.

State Research Institute for Complex Issues of Cardiovascular Diseases Municipal Budget Healthcare Institution, Kemerovo, Russia

Close metadata

References:

  1. Avrutskii G.Ya., Neduva A.A. Lechenie psikhicheski bol'nykh. M: Meditsina 1988; 486.
  2. Belova E.V. Effektivnost' primeneniya sul'pirida v lechenii bol'nykh s eroziyami i yazvami zheludka i dvenadtsatiperstnoi kishki. Klin med 2007; 7: 70-73.
  3. Butov M.A., Kuznetsov P.S., Maslova O.A. i dr. Sul'pirid v lechenii zabolevanii organov pishchevareniya. Ros zhurn gastroenterol, gepatol, koloproktol 2007; 1: 43-47.
  4. Vein A.M., Sinyachkin M.S. Sul'pirid v profilakticheskom lechenii migreni. Zhurn nevrol i psikhiat 1997; 97: 11: 28-32.
  5. Vel'tishchev D.Yu. Mnogolikii eglonil. Rus med zhurn 2001; 25: 1-10.
  6. Degtyareva I.I., Skrypnik I.N., Kozachok N.N. i dr. Effektivnost' primeneniya sul'pirida v kompleksnom lechenii bol'nykh s zabolevaniyami organov pishchevareniya. Suchasna gastroenterologiya 2002; 3: 69-76.
  7. Dorozhenok I.Yu., Terent'eva M.A. Terapiya trevozhnykh i obsessivno-kompul'sivnykh rasstroistv v dermatologicheskoi klinike: opyt primeneniya egleka (sul'pirid). Psikhiatriya i psikhofarmakoterapiya 2005; 3: 152-154.
  8. Ershov Yu.M. Effektivnost' i perenosimost' preparata "Eglek" pri lechenii trevozhnoi depressii i sostoyanii s proyavleniyami suetlivogo bespokoistva v pozhilom vozraste. Psikhiatriya i psikhofarmakoterapiya 2005; 07: 6.
  9. Zav'yalova N.E., Salmina-Khvostova O.I. Sul'pirid v lechenii shizofrenii. Ros psikhiat zhurn 2011; 3: 66-70.
  10. Ivanov S.V., Komarov F.I., Rapoport S.I. i dr. Terapiya bol'nykh s sindromom razdrazhennoi tolstoi kishki (opyt primeneniya sul'pirida). Klin med 2000; 7: 22-26.
  11. Kalinin V.V. Paradoksy eglonila - atipichnogo neiroleptika bipolyarnogo deistviya. Psikhiatriya i psikhofarmakoterapiya 2001; 6: 207-209.
  12. Klocheva E.G., Tochilov V.A. Primenenie eglonila dlya lecheniya psikhovegetativnykh narushenii. Vestnik Sankt-Peterburgskoi gosudarstvennoi meditsinskoi akademii 2000; 1: 52-54.
  13. Kostyukova E.G. Sul'pirid (eglonil) v lechenii ostrykh i khronicheskikh psikhozov. Sotsial'naya i klinicheskaya psikhiatriya 2001; 2: 97-101.
  14. L'vov A.N. Osobennosti psikhosomaticheskogo statusa u bol'nykh atopicheskim dermatitom i puti ikh kompleksnoi korrektsii: Avtoref. dis. … kand. med. nauk. M 2001.
  15. Mosolov S.N. Sovremennye tendentsii v lechenii shizofrenii. Mesto eglonila pri terapii ostrykh i khronicheskikh psikhozov. Psikhiatriya i psikhofarmakoterapiya 2000; 2: 3: 9.
  16. Nikolaev A.V. Eglonil v skheme boleutoleniya inkurabel'nykh onkologicheskikh bol'nykh. VIII Vserossiiskii s''ezd anesteziologov-reanimatologov. Tezisy dokladov 1997.
  17. Oleinik A.I., Syvolap V.V. Opyt primeneniya eglonila v gastroenterologicheskoi praktike. Suchasna gastroenterologіya 2005; 2: 87-92.
  18. Pavlenko V.V. Primenenie eglonila pri depressivnykh sostoyaniyakh u bol'nykh shizofreniei. Shizofreniya: novye podkhody k terapii. Sb. nauchnykh rabot Ukrainskogo NII klinicheskoi i eksperimental'noi nevrologii i psikhiatrii i Khar'kovskoi gorodskoi klinicheskoi psikhiatricheskoi bol'nitsy №15 (Saburovoi dachi). Pod obshch. red. I.I. Kut'ko i P.T. Petryuka. Khar'kov 1995.
  19. Reshetova T.V., Zhigalova T.N., Mozhelis Yu.V. Vozmozhnosti ispol'zovaniya farmakologicheskikh effektov betamaksa v obshchei vrachebnoi praktike. Farmateka 2007; 7: 142: 51-55.
  20. Sapronov N.S., Fedotova Yu.O. Effektivnost' primeneniya eglonila s ovestinom dlya korrektsii depressivnykh rasstroistv u zhenshchin s gipoestrogennym sindromom. Eksperimental'naya i klinicheskaya farmakologiya 2009; 4: 9-11.
  21. Smulevich A.B. Meloprogredientnaya shizofreniya. M: Meditsina 1987.
  22. Smulevich A.B., Ivanov S.V. Terapiya psikhosomaticheskikh rasstroistv. Klinicheskie effekty Eglonila (sul'pirida). Psikhiat i psikhofarmakoter 2000; 3: 6-8.
  23. Smulevich A.B. Psikhicheskie rasstroistva v klinicheskoi praktike. M: MEDpress-inform 2011; 720.
  24. Cherkasova M.V., Sergeev Yu.V. Eglonil v patogeneticheskoi terapii rozatsea. Vestn dermatol 1995; 4: 40-42.
  25. Altamura A.C., Mauri M.C., Regazzetti G., Coppola M.T. L-sulpiride in the treatment of somatoform disturbances: a double-blind study with racemic sulpiride. Minerva Psichiat 1991; 32: 1: 25-29.
  26. Asada S., Ishimaru T., Kubo S., Kodama H., Masuda K. Study of the clinical effects of sulpiride and perphenazine in 82 schizophrenic patients by the double blind method. Encephale 1976; 2: 1: 73-83.
  27. Benkert O., Holsboer F. Effect of sulpiride in endogenous depression. Acta Psychiatr Scand Suppl 1984; 311: 43-48.
  28. Bocchetta A., Bernardi F., Burrai C., Pedditzi M., Del Zompo M. A double-blind study of L-sulpiride versus amitriptyline in lithium-maintained bipolar depressives. Acta Psychiat Scand 1993; 88: 6: 434-439.
  29. Bruynooghe F., Geerts S., van Maele G., Vögtle-Junkert U. Treatment of reactive depression with sulpiride. Double-blind study with sulpiride and amitriptyline in an interindividual comparison. Fortschr Med 1992; 110: 27: 498-502.
  30. Caldara R., Masci E., Cambielli M. et al. Effect of sulpiride isomers on gastric acid and gastrin secretion in healthy man. Eur J Clin Pharmacol 1983; 25: 319-322.
  31. Caley C.F., Weber S.S. Sulpiride: an antipsychotic with selective dopaminergic antagonist properties. Ann Pharmacother 1995; 2: 29: 152-160.
  32. Cohen N., Alon I., Almoznino-Sarfian D. et al. Sulpiride versus metoclopramide in nononcologic patiets with vomiting and nausea. J Clin Gastroenterol 1999; 7: 29: 59-62.
  33. Corazza G.R., Biagi F., Albano O. et al. Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial. Ital J Gastroenterol 2000; 28: 317-323.
  34. De Maio D., Valzelli L., Scieghi G. Sulpiride and headache syndromes. Psychiat Clin (Basel) 1979; 12: 4: 202-208.
  35. Ferreri M., Florent C., Gerard D. Sulpiride: study of 669 patient presenting with pain psychological origin. Encephale 2000; 26: 58-66.
  36. Gerlach J., Peacock L. Intolerance to neuroleptic drugs: The art of avoidingextrapyramidal syndromes. Eur Psychiat 1995; 10: Suppl 1: 27-31.
  37. Guslandi M. Antiemetic properties of levosulpiride. Minerva Med 1990; 81: 12: 855-860.
  38. Herrera-Marschitz M., Stahle L., Tossman U. et al. Behavioural and biochemical studies with the benzamide sulpiride in rats. Acta Psychiat Scand Suppl 1984; 311: 147-162.
  39. Maier W., Benkert O. Treatment of chronic depression with sulpiride: evidence of efficacy in placebo-controlled single case studies. Psychopharmacology (Berl) 1994; 8: 115: 495-501.
  40. Mansi C., Savarino V., Vigneri S. et al. Effect of D2-dopamine raceptor antagonist levosulpiride on diabetic cholecystoparesis: a double-blind crossover study. Aliment Pharmacol Ther 1995; 4: 9: 185-189.
  41. Mansi C., Savarino V., Vigneri S. et al. Gastrocinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis. Am J Gastroenterol 1995; 11: 90: 1989-1993.
  42. Mauri M.C., Bravin S., Bitetto A. et al. A risk-benefit assessment of sulpiride in the treatment of schizophrenia. Drug Saf 1996; 5: 14: 288-298.
  43. Mazeman E. Dogmatil in psychosomatic urologic diseases. Lille Med 1975; 20: 1: 74-75.
  44. Memo M., Battaini F., Spano P.F. et al. Sulpiride and the role of dopaminergic receptor blockade in the antipsychotic activity of neuroleptics. Acta Psychiat Scand 1981; 4: 63: 314-324.
  45. Meyers C., Vranckx C., Elgen K. Psychosomatic disorders in general practice: comparisons of treatment with flupenthixol, diazepam and sulpiride. Pharmatherapeutica 1985; 4: 4: 244-250.
  46. Munk-Andersen E., Behnke K., Heltberg J. et al. Sulpiride versus haloperidol, a clinical trial in achizophrenia. A preliminary report. Acta Psychiat Scand Suppl 1984; 311: 31-41.
  47. O'Connor S.E., Brown R.A. The pharmacology of sulpiride - a dopamine receptor antagonist. Gen Pharmacol 1982; 13: 185-193.
  48. Pani L., Gessa G.L. The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia. Mol Psychiatry 2002; 7: 3: 247-253.
  49. Petit M., Zann M., Lesieur P., Colonna L. The effect of sulpiride on negative symptoms of schizophrenia. Br J Psychiatry 1987; 150: 270-271.
  50. Raskin S., Durst R., Katz G. et al. Olanzapine and sulpiride: a preliminary study of combination/augmentation in patients with treatment-resistant achizophrenia. J Clin Psychopharmacol 2000; 20: 500-503.
  51. Ruter E., Degner D., Munzel U. Antidepressant action of sulpiride. Results of a placebo-controlled double-blind trial. Pharmacopsychiatry 1999; 32: 127-135.
  52. Shiloh R., Zemishlany Z., Aizenberg D. et al. Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study. Br J Psychiatry 1997; 12: 171: 569-573.
  53. Soares B.G., Fenton M., Chue P. Sulpiride for schizophrenia. Cohrane Database Syst Rev 2000; Issue 2.
  54. Szabelska K., Chojnacki J., Grzegorczyk K., Mamos A. Effect of prokinetic drugs inhibiting dopaminergic system on gallbladder motility in subjects with duodenal ulcer. Pol Merkuriusz Lek 1999; 6: 34: 188-191.
  55. Toru M., Shimazono Y., Miyasaka M. et al. A double-blind comparison of sulpiride with chlorpromazine in chronic schizophrenia. J Clin Pharmacol New Drugs 1972; 12: 5: 221-229.
  56. Vandereycken W. Neuroleptics in the short-term treatment of anorexia nervosa: A double-blind placebo-controlled study with sulpiride. Br J Psychiatry 1984; 144: 288-292.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.